findmyKOL

Abid Yaqub, MD

Basic profile

Cincinnati VA Medical Center

ORCIDNPI
RegionWest Chester, OH · MidwestSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Abid Yaqub is an Endocrinology/Metabolic physician affiliated with Cincinnati VA Medical Center. OpenAlex indexes 37 publications with 258 citations (h-index 9).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
37publications

Distinct works indexed by OpenAlex, matched via ORCID.

258citations

Total citations across indexed works.

9h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
18companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

7675 Wellness Way
West Chester, OH 450692509

Telephone

513-475-7400

Registry record last updated 13 Jul 2017.

View the NPPES registry record

Industry payments

18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Hormonal (systemic)

    45.5%
    l-Thyroxine40.3%
    Levothyroxine Sodium76%Synthroid19%Tirosint3%Levoxyl2%
    Part D<11 patients
    l-Triiodothyronine1.2%
    Liothyronine Sodium100%
    Part D<11 patients

    + 4 more classes in this area

  • Metabolism & gastrointestinal

    36%
    Insulin Analog10.4%
    Lantus Solostar32%Humalog Kwikpen U-10013%Novolog Flexpen11%Toujeo Solostar9%Tresiba Flextouch U-2009%Tresiba Flextouch U-1009%Basaglar Kwikpen U-1008%Insulin Lispro Kwikpen U-1005%Novolog5%
    Part D<11 patients
    Biguanide (metformin)8.4%
    Metformin Hcl64%Metformin Hcl Er36%
    Part D28 patients

    + 6 more classes in this area

  • Cardiovascular

    12.2%
    Statin5.7%
    Atorvastatin Calcium40%Simvastatin29%Pravastatin Sodium16%Rosuvastatin Calcium15%
    Part D<11 patients
    ACE inhibitor2.1%
    Lisinopril100%
    Part D11 patients

    + 5 more classes in this area

Where care is delivered (Part B)42.5% facility · 57.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”